お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:がん分子診断の市場規模:タイプ、製品、検査場所、技術、地域別 - 2021年~2027年の予測、シェア、COVID-19の影響分析
市場調査レポート
商品コード
987622

がん分子診断の市場規模:タイプ、製品、検査場所、技術、地域別 - 2021年~2027年の予測、シェア、COVID-19の影響分析

Cancer Molecular Diagnostics Market with COVID-19 Impact Analysis, By Type, By Product, By Test Location, By Technology, and By Region - Size, Share, & Forecast from 2021-2027

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 308 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=112.06円
がん分子診断の市場規模:タイプ、製品、検査場所、技術、地域別 - 2021年~2027年の予測、シェア、COVID-19の影響分析
出版日: 2021年02月01日
発行: AnalystView Market Insights
ページ情報: 英文 308 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のがん分子診断の市場規模は、2019年までに26億3,000万米ドルとなりました。同市場は、2021年から2027年の予測期間中に17.6%のCAGRで成長する見通しです。同市場は、世界におけるがん患者数の増加により、予測期間中に着実に成長すると予測されています。

また、低侵襲の診断手法やポイントオブケア治療に対する需要の高まり、医療分野における技術の進歩、個別化の医薬品に対する認識と需要の増加、がん関連の研究開発活動、ヘルスケア費の増加などは、同市場の成長にプラスの影響を与える要因として挙げられます。さらに、新興地域からの需要の高まりに伴うプロテオミクスとゲノミクスの開発は、収益性の高い成長機会として期待されています。

ただし、新規の検査の承認を遅らせる複雑な規制の枠組みの存在や、これらの検査でタグ付けされた価格、訓練を受けた熟練した専門家の不足などは、市場成長の妨げとなっています。

当レポートは、世界のがん分子診断市場について調査しており、市場規模や予測、機会や動向、成長および抑制要因、COVID-19の影響、タイプ・製品・検査場所・技術・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場概要

第2章 エグゼクティブサマリー

  • 市場内訳
    • タイプ別
    • 製品別
    • 検査場所別
    • 技術別
    • 地域別
  • 競合考察

第3章 主な市場動向

  • 市場の成長要因
  • 市場の抑制要因
  • 市場機会
  • 市場の将来動向

第4章 業界調査

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長見通しマッピング
  • 規制の枠組み分析

第5章 COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 市場情勢

  • 市場シェア分析(2019)
  • 主要イノベーター分析
  • 主要メーカー別の内訳データ

第7章 市場分析:タイプ別

  • 概要
  • 結腸直腸がん
  • 子宮頸がん
  • 腎臓がん
  • 肝臓がん
  • 肺がん
  • 血液がん
  • 乳がん
  • 前立腺がん
  • その他

第8章 市場分析:製品別

  • 概要
  • 試薬
  • 機器
  • その他

第9章 市場分析:検査場所別

  • 概要
  • 医療施設
  • ポイントオブケア

第10章 市場分析:技術別

  • 概要
  • インサイチュハイブリダイゼーション
  • PCR
  • 等温核酸増幅技術(INAAT)
  • 質量分析
  • シーケンス
  • チップ・マイクロアレイ
  • 転写媒介増幅
  • その他

第11章 市場分析:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋(APAC)
  • ラテンアメリカ
  • 中東とアフリカ

第12章 ベンダーの分析

  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • Bayer Healthcare
    • Becton Dickinson
    • Cepheid
    • Dako
    • Danaher Corporation
    • Gen Probe
    • Qiagen NV
    • Roche Diagnostics
    • Siemens Healthcare
    • Sysmex Corporation

第13章 アナリストの見解

第14章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Molecular Diagnostics market: Types Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Types
  • TABLE Global Cancer Molecular Diagnostics market, by Types 2016-2027 (USD Million)
  • TABLE Cancer Molecular Diagnostics market: Product Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Cancer Molecular Diagnostics market, by Product 2016-2027 (USD Million)
  • TABLE Cancer Molecular Diagnostics market: Test Location Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Test Location
  • TABLE Global Cancer Molecular Diagnostics market, by Test Location 2016-2027 (USD Million)
  • TABLE Cancer Molecular Diagnostics market: Technology Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Cancer Molecular Diagnostics market, by Technology 2016-2027 (USD Million)
  • TABLE Cancer Molecular Diagnostics market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Molecular Diagnostics market, by Region 2016-2027 (USD Million)
  • TABLE North America Cancer Molecular Diagnostics market, by Country, 2016-2027 (USD Million)
  • TABLE North America Cancer Molecular Diagnostics market, by Types, 2016-2027 (USD Million)
  • TABLE North America Cancer Molecular Diagnostics market, by Product, 2016-2027 (USD Million)
  • TABLE North America Cancer Molecular Diagnostics market, by Test Location, 2016-2027 (USD Million)
  • TABLE North America Cancer Molecular Diagnostics market, by Technology, 2016-2027 (USD Million)
  • TABLE Europe Cancer Molecular Diagnostics market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Cancer Molecular Diagnostics market, by Types, 2016-2027 (USD Million)
  • TABLE Europe Cancer Molecular Diagnostics market, by Product, 2016-2027 (USD Million)
  • TABLE Europe Cancer Molecular Diagnostics market, by Test Location, 2016-2027 (USD Million)
  • TABLE Europe Cancer Molecular Diagnostics market, by Technology, 2016-2027 (USD Million)
  • TABLE Asia Pacific Cancer Molecular Diagnostics market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Cancer Molecular Diagnostics market, by Types, 2016-2027 (USD Million)
  • TABLE Asia Pacific Cancer Molecular Diagnostics market, by Product, 2016-2027 (USD Million)
  • TABLE Asia Pacific Cancer Molecular Diagnostics market, by Test Location, 2016-2027 (USD Million)
  • TABLE Asia Pacific Cancer Molecular Diagnostics market, by Technology, 2016-2027 (USD Million)
  • TABLE Latin America Cancer Molecular Diagnostics market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Cancer Molecular Diagnostics market, by Type, 2016-2027 (USD Million)
  • TABLE Latin America Cancer Molecular Diagnostics market, by Product, 2016-2027 (USD Million)
  • TABLE Latin America Cancer Molecular Diagnostics market, by Test Location, 2016-2027 (USD Million)
  • TABLE Latin America Cancer Molecular Diagnostics market, by Technology, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Cancer Molecular Diagnostics market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Cancer Molecular Diagnostics market, by Type, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Cancer Molecular Diagnostics market, by Product, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Cancer Molecular Diagnostics market, by Test Location, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Cancer Molecular Diagnostics market, by Technology, 2016-2027 (USD Million)

List of Figures

  • FIGURE Cancer Molecular Diagnostics market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Type segment market share analysis, 2020 & 2027
  • FIGURE Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Product segment market share analysis, 2020 & 2027
  • FIGURE Product segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Test Location segment market share analysis, 2020 & 2027
  • FIGURE Test Location segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Technology segment market share analysis, 2020 & 2027
  • FIGURE Technology segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Cancer Molecular Diagnostics market share and leading players, 2019
  • FIGURE Europe Cancer Molecular Diagnostics market share and leading players, 2019
  • FIGURE Asia Pacific Cancer Molecular Diagnostics market share and leading players, 2019
  • FIGURE Latin America Cancer Molecular Diagnostics market share and leading players, 2019
  • FIGURE Middle East and Africa Cancer Molecular Diagnostics market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Cancer Molecular Diagnostics market share analysis by country, 2019
  • FIGURE Germany Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Cancer Molecular Diagnostics market share analysis by country, 2019
  • FIGURE India Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Cancer Molecular Diagnostics market share analysis by country, 2019
  • FIGURE Brazil Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Cancer Molecular Diagnostics market share analysis by country, 2019
  • FIGURE Saudi Arabia Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Cancer Molecular Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
目次

REPORT HIGHLIGHT

The global cancer molecular diagnostics market was valued at USD 2.63 billion by 2019, growing with 17.6% CAGR during the forecast period, 2021-2027.

The molecular diagnostics test is capable of detecting a specific biologic molecule or biomarker in the fluid sample or tissues of the patient. It can be further used to select a cancer therapy and even aids in observing the treatment effects based on changes witnessed by the biomarker. The cancer molecular diagnostics market is expected to witness steady growth during the forecast period, owing to the increasing count of cancer patients worldwide. According to the American Cancer Society's 2020 report, the count of new cancer patients was estimated to be 1.8 million with 606,520 cancer deaths in the US alone.

Growing demand for point of care treatments along with minimally invasive diagnostic procedures also boosts the business growth. Technological advancements witnessed in the healthcare sector, increasing awareness and demand for customized medications, cancer-related research and development activities, and the blooming healthcare expenses are some other factors that are responsible for influencing the cancer molecular diagnostics market growth in a positive direction.

On the contrary, the price tagged with these tests coupled with the existence of a complex regulatory framework delaying the approval of new tests serves to be growth restraining factors responsible for depleting the demand for molecular testing across the globe. Besides, the developments in proteomics and genomics with the growing demand from developing regions offers lucrative business growth opportunities. Whereas, the lack of trained and skilled professionals hampers the application of new molecular diagnostic techniques, restricting the business growth rate.

Over to the type section, the market growth is dominated by the breast cancer segment, accounting for the availability of large test volumes with the accessibility to commercialized products. The data presented in GLOBOCAN 2020 unveiled that breast cancer accounts for 1 in 4 cancers diagnosed among women worldwide. Also, the colorectal cancer segment followed by the liver cancer and prostate cancer segment is expected to have a significant growth rate in the next few years.

The product segment is governed by the reagents section, owing to the application of numerous reagents in cancer-related studies. At the same time, the instruments segment is expected to have a steady growth in the next few years, which is supported by the growing demand for rapid and accurate diagnostics devices.

The polymerase chain reaction leads the technology segment followed by the genetic sequencing segment. Based on test locations, the segmental growth is acknowledged by clinics, owing to the high volume of molecular diagnostic tests. The point of care segment is likely to be the fastest-growing segment in the near future, accounting for the growing healthcare spending, raising awareness, and the robust demand for rapid testing.

Regionally, it is estimated that North America accounts to have the largest regional market, followed by Europe. Factors such as the established healthcare infrastructure and the rising awareness about good health are responsible for boosting the North American cancer molecular diagnostics market shares. As for emerging nations, the market growth accumulates to the high incidence of cancer among low and middle-income countries followed by the presence of a large geriatric population base with high unmet needs of patients.

The cancer molecular diagnostics market size is also influenced by the strategies adopted by the prominent market players to enhance their business growth with geographical existence. Such initiatives include mergers and acquisitions, partnerships, collaborations, new product launches, etc. For instance, in February 2021, Oncocyte Corporation signed an agreement to acquire Chronix Biomedical Inc., enhancing the molecular diagnostics product portfolio.

Key features of the study:

  • This proposed research study on the cancer molecular diagnostics market provides market size (US$ million), compound annual growth rate (CAGR %), and forecast estimation (2020-2027), considering 2019 as the base year
  • The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the cancer molecular diagnostics market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the cancer molecular diagnostics market
  • The impact of COVID-19 on cancer molecular diagnostics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on the cancer molecular diagnostics market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the cancer molecular diagnostics market, we have also included a competitive landscape and key innovator analysis for the cancer molecular diagnostics market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate, and end-user's attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the cancer molecular diagnostics market.
  • In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new product launches, research & development, regional expansion of major participants involved in the cancer molecular diagnostics market on a global as well as regional level.
  • The global cancer molecular diagnostics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER MOLECULAR DIAGNOSTICS MARKET KEY PLAYERS

Abbott Laboratories

Bayer Healthcare

Becton Dickinson

Cepheid

Dako

Danaher Corporation

Gen Probe

Qiagen N.V.

Roche Diagnostics

Siemens Healthcare

Sysmex Corporation

GLOBAL CANCER MOLECULAR DIAGNOSTICS MARKET, BY TYPE

Blood cancer

Kidney cancer

Colorectal cancer

Liver cancer

Lung cancer

Breast cancer

Cervical cancer

Prostate cancer

Others

GLOBAL CANCER MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT

Reagents

Instruments

Others

GLOBAL CANCER MOLECULAR DIAGNOSTICS MARKET, BY TEST LOCATION

Point of Care

Clinical Facilities

GLOBAL CANCER MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY

In Situ Hybridization

Isothermal Nucleic Acid Amplification Technology (INAAT)

PCR

Multiplex

Others

Mass spectrometry

Sequencing

Transcription Mediated Amplification

Chips and microarrays

Others

GLOBAL CANCER MOLECULAR DIAGNOSTICS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. Cancer Molecular Diagnostics Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Type
    • 2.1.2. Market Snippet by Product
    • 2.1.3. Market Snippet by Test Location
    • 2.1.4. Market Snippet by Technology
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Molecular Diagnostics Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Cancer Molecular Diagnostics Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Molecular Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Molecular Diagnostics Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Cancer Molecular Diagnostics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2020 & 2027 (%)
  • 7.2. Colorectal cancer
  • 7.3. Cervical cancer
  • 7.4. Kidney cancer
  • 7.5. Liver cancer
  • 7.6. Lung cancer
  • 7.7. Blood cancer
  • 7.8. Breast cancer
  • 7.9. Prostate cancer
  • 7.10. Others

8. Cancer Molecular Diagnostics Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2020 & 2027 (%)
  • 8.2. Reagents
  • 8.3. Instruments
  • 8.4. Others

9. Cancer Molecular Diagnostics Market - By Test Location

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Test Location, 2020 & 2027 (%)
  • 9.2. Clinics Facilities
  • 9.3. Point of Care

10. Cancer Molecular Diagnostics Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2020 & 2027 (%)
  • 10.2. In Situ Hybridization
  • 10.3. PCR
    • 10.3.1. Multiplex
    • 10.3.2. Others
  • 10.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
  • 10.5. Mass spectrometry
  • 10.6. Sequencing
  • 10.7. Chips and microarrays
  • 10.8. Transcription Mediated Amplification
  • 10.9. Others

11. Cancer Molecular Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.1. Canada Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 1.1.1.2. Canada Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 1.1.1.3. Canada Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 1.1.1.4. Canada Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.3.12. Rest of Europe
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.3.12.3. Rest of the Europe Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.3.12.4. Rest of the Europe Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.3.12.5. Rest of the Europe Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.3.12.6. Rest of the Europe Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.4.12. Rest of APAC
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.4.12.3. Rest of APAC Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.4.12.4. Rest of APAC Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.4.12.5. Rest of APAC Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.4.12.6. Rest of APAC Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.5.11. Rest of LATAM
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.5.11.5. Rest of LATAM Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.5.11.6. Rest of LATAM Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Location, 2016 - 2027 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)

12. Key Vendor Analysis

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Bayer Healthcare
    • 12.2.3. Becton Dickinson
    • 12.2.4. Cepheid
    • 12.2.5. Dako
    • 12.2.6. Danaher Corporation
    • 12.2.7. Gen Probe
    • 12.2.8. Qiagen N.V.
    • 12.2.9. Roche Diagnostics
    • 12.2.10. Siemens Healthcare
    • 12.2.11. Sysmex Corporation

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.